These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
288 related items for PubMed ID: 9472836
1. Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study. Wetzel H, Anghelescu I, Szegedi A, Wiesner J, Weigmann H, Härter S, Hiemke C. J Clin Psychopharmacol; 1998 Feb; 18(1):2-9. PubMed ID: 9472836 [Abstract] [Full Text] [Related]
2. Addition of low-dose fluvoxamine to low-dose clozapine monotherapy in schizophrenia: drug monitoring and tolerability data from a prospective clinical trial. Szegedi A, Anghelescu I, Wiesner J, Schlegel S, Weigmann H, Härtter S, Hiemke C, Wetzel H. Pharmacopsychiatry; 1999 Jul; 32(4):148-53. PubMed ID: 10505485 [Abstract] [Full Text] [Related]
4. Effect of coadministration of clozapine and fluvoxamine versus clozapine monotherapy on blood cell counts, plasma levels of cytokines and body weight. Hinze-Selch D, Deuschle M, Weber B, Heuser I, Pollmächer T. Psychopharmacology (Berl); 2000 Apr; 149(2):163-9. PubMed ID: 10805611 [Abstract] [Full Text] [Related]
10. Dose-dependent pharmacokinetic interaction of clozapine and paroxetine in an extensive metabolizer. Joos AA, König F, Frank UG, Kaschka WP, Mörike KE, Ewald R. Pharmacopsychiatry; 1997 Nov; 30(6):266-70. PubMed ID: 9442550 [Abstract] [Full Text] [Related]
11. The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine. Azuma J, Hasunuma T, Kubo M, Miyatake M, Koue T, Higashi K, Fujiwara T, Kitahara S, Katano T, Hara S. Eur J Clin Pharmacol; 2012 Jan; 68(1):29-37. PubMed ID: 21739267 [Abstract] [Full Text] [Related]
13. Plasma concentrations of clozapine and its major metabolites during combined treatment with paroxetine or sertraline. Spina E, Avenoso A, Salemi M, Facciolá G, Scordo MG, Ancione M, Madia A. Pharmacopsychiatry; 2000 Nov; 33(6):213-7. PubMed ID: 11147928 [Abstract] [Full Text] [Related]
18. Clozapine and paroxetine in the treatment of schizophrenia with obsessive-compulsive features. Strous RD, Patel JK, Zimmet S, Green AI. Am J Psychiatry; 1999 Jun; 156(6):973-4. PubMed ID: 10360153 [No Abstract] [Full Text] [Related]
19. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder. Dannon PN, Iancu I, Lowengrub K, Gonopolsky Y, Musin E, Grunhaus L, Kotler M. Clin Neuropharmacol; 2007 Jun; 30(6):326-34. PubMed ID: 18090457 [Abstract] [Full Text] [Related]
20. Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors. Centorrino F, Baldessarini RJ, Frankenburg FR, Kando J, Volpicelli SA, Flood JG. Am J Psychiatry; 1996 Jun; 153(6):820-2. PubMed ID: 8633698 [Abstract] [Full Text] [Related] Page: [Next] [New Search]